Uniting global leaders to shape the future of research and care in rheumatic and musculoskeletal diseases.
—
The European Alliance of Associations for Rheumatology (EULAR) is now accepting press registrations for its flagship event, the EULAR 2026 Congress, taking place from 3–6 June at the Excel London. This international gathering will spotlight the latest breakthroughs in rheumatic and musculoskeletal diseases (RMDs), bringing together top-tier scientists, clinicians, and healthcare professionals.
As a premier event in the field of rheumatology, this year’s Congress promises another bold scientific programme featuring new clinical data and updated treatment guidelines as well as emerging therapies, cutting-edge technologies and patient-centred approaches transforming the RMD landscape.
- Rare Disease: focusing on advances in rare rheumatic conditions and underscoring the importance of tailored research and treatment strategies.
- AI in Rheumatology: sessions will explore the growing role of artificial intelligence in the field, from predictive diagnostics to personalised care pathways.
- Women’s Health: dedicated tracks will address sex and gender differences in RMDs, aiming at improving outcomes across lifespan.
- Public Health: showcasing different perspectives, emphasising prevention, equity, and global strategies to reduce the burden of RMDs.
What’s new for delegates
- Bring Your Own Device (BYOD): to continue making an impact to sustainability and increase accessibility, attendees can use their own devices to explore poster sessions and Meet the EULAR Expert sessions.
- Expanded Access:
- Young Rheumatologists: a new registration category supports professionals being in their first three years of practice.
- Global Inclusion: delegates residing in low- and low/middle income countries receive a 50% reduction on registration fees.
Additionally, the programme has further been adjusted to better accommodate delegate requests. Abstract and Case Report Submissions are open since 1 October 2025.
“We warmly welcome the media to join us in London as we highlight the global momentum in rheumatic and musculoskeletal diseases”, said Prof Xenofon Baraliakos, EULAR President. “Your coverage helps ensure that the latest research, technologies and treatment advances reach communities, patients and clinicians around the world”.
Exclusive media opportunities
Members of the press are invited to attend the official EULAR press conference on 4 June 2026 to learn more about recent breakthroughs and upcoming challenges in RMD research and care as well as to benefit from one-on-one interview access with expert panellists.
Press credentials and info
To apply for media accreditation or explore the Congress programme, visit:
EULAR 2026 - Press Registration
We look forward to welcoming you to London for an inspiring and impactful EULAR 2026 Congress.
About EULAR
EULAR is the European umbrella organisation representing scientific societies, health professional associations and organisations for people with RMDs. EULAR aims to reduce the impact of RMDs on individuals and society, as well as improve RMD treatments, prevention, and rehabilitation. To this end, EULAR fosters excellence in rheumatology education and research, promotes the translation of research advances into daily care, and advocates for the recognition of the needs of those living with RMDs by EU institutions.
Contact
EULAR Communications,
communications@eular.org